15. ASC Farmacoepidemiologia e Farmacoutilizzazione

Programma

MANDATO 2024-2028

Progetti in corso

MANDATO 2024-2028

Comunicazioni e documenti

MANDATO 2024-2028

Sezione in aggiornamento

Indice delle pubblicazioni

MANDATO 2024-2028

• Romagnoli A, Savoia M, Papini G, Caprodossi A, Bartolini F. Adherence and persistence rates for antidiabetic treatments in type 2 diabetes: a real-world study in an Italian region. Eur J Hosp Pharm. 2025 Feb 26:ejhpharm-2024-004383. doi: 10.1136/ ejhpharm-2024-004383. Epub ahead of print. PMID: 40015721.
• Musicco F, Lasala R, Santoleri F, Costantini A, Abrate P, Romagnoli A, Terrenato I. Aderenza e persistenza come indicatori di esito in tempo reale dei trattamenti farmacologici oncoematologici e il caso degli anti-EGFR in prima linea nello NSCLC. Recenti Prog Med. 2024 Nov;115(11):547-549.
• Romagnoli A, Zovi A, Santoleri F, Lasala R. Antidepressant deprescribing: State of the art and recommendations-A literature overview. Eur J Clin Pharmacol. 2024 Jan 8. doi: 10.1007/s00228-023-03617-x. Epub ahead of print. PMID: 38189859.
• Romagnoli A, Di Tommaso R, Guarino FR, Colanardi P, De Vita F, D’Ovidio P. Modelli di utilizzo degli inibitori del PCSK9:analisi di aderenza, persistenza ed appropriatezza prescrittiva in real life. GIFAC 2023;37(2):38-45. doi 10.1721/4049.40304.
• Lasala R, Zovi A, Isgrò V, Romagnoli A, Musicco F, Santoleri F. Time to treatment discontinuation in first-line non-small cellnlung carcinoma: an overview. Curr Med Res Opin. 2023 Mar 24:1-10. doi:10.1080/03007995.2023.2192610. Epub ahead of print. PMID: 36932463.
• Romagnoli A, Santoleri F, Costantini A, Di Risio A. Adherence, persistence and switching rates of apixaban, dabigatran and rivaroxaban in non-valvular atrial fibrillation: a multicentre real-life analysis at 3 years. Eur J Hosp Pharm. 2022 Aug 12.
• Alessia Romagnoli, Fiorenzo Santoleri, Alberto Costantini. Valutazione dell’impatto dell’aderenza al trattamento ipoglicemizzante sull’efficacia della terapia utilizzando gli esiti del ricovero ospedaliero GIFAC 2022; 36(1):31-40
• Alessia Romagnoli, Patrizia D’Ovidio, Rosalba Di Tommaso, Francesca Romana Guarino, Angelora Di Risio. Analisi di sopravvivenza globale in real life nei pazienti con ossigenoterapia a lungo termine (OTLT). GIFaC 2021; 35(3-4): 142-148
• Lasala R, Santoleri F, Romagnoli A, Abrate P, Musicco F, Costantini A. Medication adherence reporting in pivotal clinical trials: overview of oral oncological drugs. Eur J Hosp Pharm. 2022 Jan 20:ejhpharm-2021-002998.
• Romagnoli A, Santoleri F, Costantini A. The impact of COVID-19 on chronic therapies: the Pescara (ASL) local health authority experience in Italy. Curr Med Res Opin. 2021 Dec 10.
• Santoleri F, Romagnoli A, Costantini A. Adherence and persistence in the use of statins and ezetimibe over 8 years in a reallife study. Curr Med Res Opin. 2021 Dec.
• Lasala R, Santoleri F, Zanon D, Romagnoli A, Abrate P, Costantini A, Musicco F. Available information about paediatric use of onco-haematological drugs authorized by EMA since 2016. J Oncol Pharm Pract. 2021 Oct 23.
• Lasala R, Santoleri F, Romagnoli A, Musicco F, Abrate P, Costantini A. Randomized clinical trials and real life studies: Comparison of baseline characteristics of patients in oral target therapies for renal cell carcinoma. J Oncol Pharm Pract. 2021 Apr.
• Romagnoli A, Santoleri F, Costantini A. Drug utilisation pattern over 3 years in the real-world treatment of type II diabetes. Int J Clin Pract. 2021 Jun.
• Romagnoli A., Santoleri F., Costantini A. Adherence and persistence analysis in patients treated with double antiplatelet therapy (DAPT) at two years in real life. Patient Educ Couns. 2021 Jan 12.
• Romagnoli A., Santoleri F., Costantini A.,Adherence and persistence analysis after three years in real-life of inhalation therapies used in the treatment of COPD. Curr Med Res Opin 2020 Oct 23;1.
• Santoleri F, Romagnoli A, Costantini A. Real-life adherence in capecitabine therapy using two analysis methods and persistence after 6 months of treatment. J Oncol Pharm Pract. 2020 Aug.
• Romagnoli A, Santoleri F, Costantini A. Long-acting injectable vs oral antipsychotics: Adherence, persistence and switching over three years of real-life analysis. Curr Clin Pharmacol. 2020 Mar 9.
• Santoleri F, Romagnoli A, Costantini A. Adalimumab and etanercept adherence, persistence and switch in the treatment of psoriatic arthritis: 10-year real-life analysis. Expert Opin Drug Saf. 2020 Jan.
• Felice Musicco, Paolo Abrate, Ruggero Lasala, Fiorenzo Santoleri, Alessia Romagnoli, Alberto Costantini, Diana Giannarelli, Irene Terrenato. Real-world clinical outcomes in metastatic breast cancer patients treated with palbociclib.J Oncol Pharm Practice 2019, Vol. 25 8(Supplement) 1–116.
• Santoleri F, Romagnoli A, Costantini A. Use and costs of originator and biosimilar erythropoiesisstimulating agents in the treatment of chemotherapy-induced anemia: real-world evidence from an Italian hospital. Future Oncol. 2018 Nov 23.
• Fiorenzo Santoleri, Alessia Romagnoli, Alberto Costantini. L'aderenza al trattamento nei farmaci oncologici.

Archivio anni precedenti

MANDATO 2020-2024

Composizione

Coordinatore:

Felice Simiele

 

Componenti

Paolo Abrate

 

Cosimo De Giorgio

 

Chiara Fulgenzio

 

Valentina Isgrò

 

Ruggero Lasala

 

Fiorenzo Santoleri

 

Alice Stievano